In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cyberonics Stumbles and ANS Lends a Hand

Executive Summary

An unexpected and unfavorable ruling from the FDA has left Cyberonics officials angry and frustrated and has put in jeopardy the depression opportunity the company was counting on. Also on Cyberonics' plate: an unwelcome merger bid from rival neurostimulation company, ANS.
Advertisement

Related Content

Neuronetics' FDA Nod Opens Doors to New CNS Market
Building Medtronic Neuro by Trial: An Interview with Richard Kuntz, MD
Seizure Desist: Neurostim Companies Pursue Alternative Treatments for Epilepsy
Neurostimulation Market Expanding
Neuromodulation: Devices's Stimulating Growth Market
Neuronetics Inc.
Concentric's Clearance Not Likely to Spur Stroke Investment
Cyberonics and Depression's Happy Face
ANS Goes Along For The Ride
Cyberonics On Its Own

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV002403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel